Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivity (Q27642760)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivity	scientific article

Statements

scholarly article

0 references

Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivity (English)

0 references

crystal structure

0 references

5

object named as

Hengming Ke

0 references

author name string

Qing Huai

1

0 references

Yudong Liu

2

0 references

Sharron H Francis

3

0 references

Jackie D Corbin

4

0 references

language of work or name

0 references

publication date

26 March 2004

0 references

Journal of Biological Chemistry

0 references

279

0 references

13

0 references

13095-101

0 references

Molecular diversity of cyclic AMP signalling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Nitric oxide and the other cyclic nucleotide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Reinventing the wheel of cyclic AMP: novel mechanisms of cAMP signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Cyclic GMP phosphodiesterase-5: target of sildenafil

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Diversity in cyclic nucleotide phosphodiesterase isoenzyme families

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

cGMP-inhibited phosphodiesterases (PDE3 gene family).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Therapeutic potential of cyclic nucleotide phosphodiesterase inhibitors in heart failure

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

The next generation of PDE4 inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Phosphodiesterase 5 inhibitors: current status and potential applications

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

New phosphodiesterase inhibitors as therapeutics for the treatment of chronic lung disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Phosphodiesterase 4 inhibitors for the treatment of COPD.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Crystal structure of phosphodiesterase 4D and inhibitor complex(1)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Processing of X-ray diffraction data collected in oscillation mode

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Improved methods for building protein models in electron density maps and the location of errors in these models

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

The CCP4 suite: programs for protein crystallography

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M311556200

21 January 2018

Identifiers

10.1074/JBC.M311556200

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27642760&oldid=1947973933"